Topics

"Physical Inactivity Associated with Excess Risk Dementia" Drugs and Medication Database

18:24 EDT 16th September 2019 | BioPortfolio

Here are the most relevant "Physical Inactivity Associated with Excess Risk Dementia" Drugs and Medications that we have found in our database.

More Information about "Physical Inactivity Associated with Excess Risk Dementia" on BioPortfolio

We have published hundreds of Physical Inactivity Associated with Excess Risk Dementia news stories on BioPortfolio along with dozens of Physical Inactivity Associated with Excess Risk Dementia Clinical Trials and PubMed Articles about Physical Inactivity Associated with Excess Risk Dementia for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Physical Inactivity Associated with Excess Risk Dementia Companies in our database. You can also find out about relevant Physical Inactivity Associated with Excess Risk Dementia Drugs and Medications on this site too.

Showing "Physical Inactivity Associated with Excess Risk Dementia" Drugs and Medications 1–25 of 169

Possibly Relevant

Rivastigmine tartrate [sandoz inc]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules. Rivastigmine Tartrate Capsules, for oral use Initial U.S. Approva

Rivastigmine tartrate [alembic pharmaceuticals limited]

These highlights do not include all the information needed to use Rivastigmine Tartrate Capsules USP safely and effectively. See full prescribing information for Rivastigmine Tartrate Capsules USP. Rivastigmine Tartrate Capsules USP, for oral use.Initial

Rexulti [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use REXULTI safely and effectively. See full prescribing information for REXULTI. REXULTI (brexpiprazole) tablets, for oral use Initial U.S. Approval: 2015

Rivastigmine [amneal pharmaceuticals llc]

These highlights do not include all the information needed to use RIVASTIGMINE TRANSDERMAL SYSTEM safely and effectively. See full prescribing information for RIVASTIGMINE TRANSDERMAL SYSTEM.   RIVASTIGMINE transdermal system Initial U.S. Approval: 2000

Risperidone [wockhardt limited]

These highlights do not include all the information needed to use risperidone safely and effectively. See full prescribing information for risperidone. Risperidone Tablets Initial U.S. Approval : 1993

Olanzapine and fluoxetine [par pharmaceutical, inc.]

These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE AND FLUOXETINE CAPSULES, for oral use. Initial

Olanzapine and fluoxetine [sandoz inc]

These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral use. Initial

Latuda [sunovion pharmaceuticals inc.]

These highlights do not include all the information needed to use LATUDA safely and effectively. See full prescribing information for LATUDA.LATUDA (lurasidone hydrochloride) tablets, for oral use Initial U.S. Approval: 2010

Symbyax [eli lilly and company]

These highlights do not include all the information needed to use SYMBYAX safely and effectively. See full prescribing information for SYMBYAX.SYMBYAX (olanzapine and fluoxetine) capsules for oral useInitial U.S. Approval: 2003

Fluorishield [young dental manufacturing i, llc]

NA

Olanzapine and fluoxetine [avkare, inc.]

Olanzapine and Fluoxetine Capsules USP Rx Only These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE

Olanzapine and fluoxetine [teva pharmaceuticals usa, inc.]

These highlights do not include all the information needed to use OLANZAPINE AND FLUOXETINE CAPSULES safely and effectively. See full prescribing information for OLANZAPINE AND FLUOXETINE CAPSULES. OLANZAPINE and FLUOXETINE capsules, for oral useInitial U

Nuplazid [acadia pharmaceuticals inc]

These highlights do not include all the information needed to use NUPLAZID safely and effectively. See full prescribing information for NUPLAZID. NUPLAZID (pimavanserin) capsules, for oral use NUPLAZID (pimavanserin) tablets, for oral use Initial U.S. App

Progesterone [preferred pharmaceuticals inc.]

Progesterone Capsules 100 mg Capsules 200 mg

Progesterone [akorn, inc.]

ProgesteroneCapsules 100 mgCapsules 200 mg

Progesterone [a-s medication solutions]

ProgesteroneCapsules 100 mgCapsules 200 mg

Progesterone [bryant ranch prepack]

ProgesteroneCapsules 100 mgCapsules 200 mg

Rivastigmine transdermal system [alvogen inc.]

These highlights do not include all the information needed to use Rivastigmine Patch safely and effectively. See full prescribing information for Rivastigmine Patch. RIVASTIGMINE transdermal system Initial U.S. Approval: 2000

Fluphenazine hydrochloride [tya pharmaceuticals]

Fluphenazine Hydrochloride Tablets, USP

Fluphenazine hydrochloride [sandoz inc]

Fluphenazine Hydrochloride Tablets, USP

Vraylar [allergan, inc.]

These highlights do not include all the information needed to use VRAYLAR safely and effectively. See full prescribing information for VRAYLAR .     VRAYLAR ( cariprazine )   c apsules ,   for o ral u se Initial U.S. Approval: 2015

Loxapine [remedyrepack inc.]

Loxapine Capsules USP Revised: September 2010 Rx only 174374-2

Loxapine [carilion materials management]

Loxapine Capsules USP Revised: September 2010 Rx only 174374-2

Saphris [allergan, inc.]

These highlights do not include all the information needed to use SAPHRIS (asenapine) sublingual tablets safely and effectively. See full prescribing information for SAPHRIS.SAPHRIS (asenapine) sublingual tabletsInitial U.S. Approval: 2009

Combipatch (estradiol/norethindrone acetate transdermal system) [noven therapeutics, llc]

CombiPatch (estradiol/norethindrone acetate transdermal system) Rx only Prescribing Information



Quick Search